Vadim Makarov

Часть публикаций из профиля, по году от новых к старым. Это не полный список последних работ автора; работы без года — в конце.

• A Proof-of-Concept Study for the Efficacy of Dispirotripiperazine PDSTP in a Mouse Model of Herpes Simplex Herpetic Encephalitis2026
• Design and anti-rhinovirus activity of novel derivatives based on the pleconaril core2026
• Enhanced Antiviral Activity of Novel Umifenovir Derivativesagainst SARS-CoV-2: Insights from an International Collaborative Study2026
• Effective influenza treatment: a comprehensive review of challenges and advances2026
• Vindeburnol Induces Neuroprotection in Rat Traumatic Brain Injury via Adrenergic Receptor Antagonism2026
• Towards a new combination therapy for tuberculosis with next generation benzothiazinones2014 · аннотациясвернуть

  The benzothiazinone lead compound, BTZ043, kills Mycobacterium tuberculosis by inhibiting the essential flavo-enzyme DprE1, decaprenylphosphoryl-beta-D-ribose 2-epimerase. Here, we synthesized a new series of…

• Benzothiazinones Are Suicide Inhibitors of Mycobacterial Decaprenylphosphoryl-β- d -ribofuranose 2′-Oxidase DprE12011
• Benzothiazinones: Prodrugs That Covalently Modify the Decaprenylphosphoryl-β- d -ribose 2′-epimerase DprE1 of Mycobacterium tuberculosis2010 · аннотациясвернуть

  Benzothiazinones (BTZs) form a new class of potent antimycobacterial agents. Although the target of BTZs has been identified as decaprenylphosphoryl-β-D-ribose 2'-epimerase (DprE1), their detailed mechanism of action…